Patrick Brassil

1.9k total citations
28 papers, 1.2k citations indexed

About

Patrick Brassil is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Patrick Brassil has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Pharmacology. Recurrent topics in Patrick Brassil's work include Pharmacogenetics and Drug Metabolism (7 papers), Cancer therapeutics and mechanisms (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Patrick Brassil is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Cancer therapeutics and mechanisms (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Patrick Brassil collaborates with scholars based in United States, United Kingdom and Germany. Patrick Brassil's co-authors include James R. Burke, Wendy Clarke, Kurt R. Gregor, Yuping Qiu, Mark A. Pattoli, Kim W. McIntyre, F. Christopher Zusi, Joann Strnad, John F. MacMaster and Xiaoxia Yang and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Patrick Brassil

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Brassil United States 18 548 272 256 214 210 28 1.2k
Nathan A. Lack Türkiye 22 668 1.2× 169 0.6× 111 0.4× 124 0.6× 218 1.0× 55 1.4k
Natale D’Alessandro Italy 23 887 1.6× 362 1.3× 234 0.9× 265 1.2× 116 0.6× 57 1.6k
Huameng Li United States 15 417 0.8× 335 1.2× 87 0.3× 95 0.4× 143 0.7× 19 946
P. Benedetti Panici Italy 23 658 1.2× 496 1.8× 158 0.6× 94 0.4× 133 0.6× 53 1.7k
T. E. Witzig United States 8 879 1.6× 427 1.6× 193 0.8× 133 0.6× 177 0.8× 13 1.5k
N. Hirayama Japan 19 776 1.4× 100 0.4× 146 0.6× 176 0.8× 127 0.6× 81 1.4k
Helena Almqvist Sweden 9 902 1.6× 225 0.8× 88 0.3× 115 0.5× 100 0.5× 12 1.3k
Aijun Shen China 23 1.0k 1.9× 353 1.3× 255 1.0× 181 0.8× 266 1.3× 39 1.6k
Valentina Zuco Italy 27 1.8k 3.2× 579 2.1× 401 1.6× 420 2.0× 110 0.5× 70 2.4k
Helen Boyd United Kingdom 20 743 1.4× 161 0.6× 283 1.1× 129 0.6× 111 0.5× 43 1.5k

Countries citing papers authored by Patrick Brassil

Since Specialization
Citations

This map shows the geographic impact of Patrick Brassil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Brassil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Brassil more than expected).

Fields of papers citing papers by Patrick Brassil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Brassil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Brassil. The network helps show where Patrick Brassil may publish in the future.

Co-authorship network of co-authors of Patrick Brassil

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Brassil. A scholar is included among the top collaborators of Patrick Brassil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Brassil. Patrick Brassil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maher, Jonathan, Rui Zhang, Gopinath S. Palanisamy, et al.. (2022). Lung-restricted ALK5 inhibition avoids systemic toxicities associated with TGFβ pathway inhibition. Toxicology and Applied Pharmacology. 438. 115905–115905. 7 indexed citations
2.
Beattie, David T., et al.. (2017). Intestinally-restricted Janus Kinase inhibition: a potential approach to maximize the therapeutic index in inflammatory bowel disease therapy. Journal of Inflammation. 14(1). 28–28. 21 indexed citations
3.
Bolleddula, Jayaprakasam, Kevin DeMent, James P. Driscoll, et al.. (2014). Biotransformation and bioactivation reactions of alicyclic amines in drug molecules. Drug Metabolism Reviews. 46(3). 379–419. 60 indexed citations
4.
Hu, Shuanghua, Yong‐Jin Wu, Huan He, et al.. (2014). Structure activity relationship studies of 3-arylsulfonyl-pyrido[1,2-a]pyrimidin-4-imines as potent 5-HT6 antagonists. Bioorganic & Medicinal Chemistry. 22(5). 1782–1790. 17 indexed citations
5.
Peer, Cody J., Jeffrey L. Brown, Jeffrey A. Roth, et al.. (2013). A novel uHPLC–MS/MS method for the quantitation of AZD7451 (AZ12607092) in human plasma. Journal of Chromatography B. 942-943. 107–112. 1 indexed citations
6.
Oza, Vibha, Susan Ashwell, Patrick Brassil, et al.. (2012). Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(6). 2330–2337. 19 indexed citations
7.
Yang, Bin, Alexander W. Hird, Daniel Russell, et al.. (2012). Discovery of novel hedgehog antagonists from cell-based screening: Isosteric modification of p38 bisamides as potent inhibitors of SMO. Bioorganic & Medicinal Chemistry Letters. 22(14). 4907–4911. 15 indexed citations
8.
Ballard, Peter, Patrick Brassil, Khanh Bui, et al.. (2012). The right compound in the right assay at the right time: an integrated discovery DMPK strategy. Drug Metabolism Reviews. 44(3). 224–252. 37 indexed citations
9.
Reck, Folkert, Richard A. Alm, Patrick Brassil, et al.. (2012). Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II with Reduced pKa: Antibacterial Agents with an Improved Safety Profile. Journal of Medicinal Chemistry. 55(15). 6916–6933. 65 indexed citations
10.
McGinnity, Dermot F., George Zhang, Jane R. Kenny, et al.. (2009). Evaluation of Multiple in Vitro Systems for Assessment of CYP3A4 Induction in Drug Discovery: Human Hepatocytes, Pregnane X Receptor Reporter Gene, and Fa2N-4 and HepaRG Cells. Drug Metabolism and Disposition. 37(6). 1259–1268. 64 indexed citations
11.
Goteti, Kosalaram, C. Edwin Garner, Jing Dai, et al.. (2009). Preclinical pharmacokinetic/pharmacodynamic models to predict synergistic effects of co-administered anti-cancer agents. Cancer Chemotherapy and Pharmacology. 66(2). 245–254. 26 indexed citations
12.
Goteti, Kosalaram, Patrick Brassil, Steven S. Good, & C. Edwin Garner. (2008). Estimation of Human Drug Clearance Using Multiexponential Techniques. The Journal of Clinical Pharmacology. 48(10). 1226–1236. 18 indexed citations
13.
Harper, Timothy W. & Patrick Brassil. (2008). Reaction Phenotyping: Current Industry Efforts to Identify Enzymes Responsible for Metabolizing Drug Candidates. The AAPS Journal. 10(1). 200–207. 33 indexed citations
14.
Belema, Makonen, Amy Bunker, Van N. Nguyen, et al.. (2007). Synthesis and structure–activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-β inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(15). 4284–4289. 26 indexed citations
15.
Taber, Matthew T., Thaddeus F. Molski, Wendy Clarke, et al.. (2005). Neurochemical, pharmacokinetic, and behavioral effects of the novel selective serotonin reuptake inhibitor BMS-505130. Pharmacology Biochemistry and Behavior. 80(3). 521–528. 17 indexed citations
16.
Burke, James R., Mark A. Pattoli, Kurt R. Gregor, et al.. (2003). BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in Mice. Journal of Biological Chemistry. 278(3). 1450–1456. 439 indexed citations
17.
Burke, James R., Paul Stanley, Kurt R. Gregor, et al.. (2001). BMS-229724 Is a Tight-Binding Inhibitor of Cytosolic Phospholipase A2 That Acts at the Lipid/Water Interface and Possesses Anti-Inflammatory Activity in Skin Inflammation Models. Journal of Pharmacology and Experimental Therapeutics. 298(1). 376–385. 27 indexed citations
18.
Schulz, Thomas, Renate Thiel, Diether Neubert, et al.. (2001). Assessment of P450 induction in the marmoset monkey using targeted anti-peptide antibodies. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1546(1). 143–155. 17 indexed citations
19.
Brassil, Patrick, et al.. (1998). Reduced Hepatic Expression of CYP7A1 and CYP2C13 in Rats with Spontaneous Hyperlipidaemia. Biochemical Pharmacology. 56(2). 253–257. 8 indexed citations
20.
Brassil, Patrick, Robert J. Edwards, & Donald S. Davies. (1995). Expression and distribution of cholesterol 7α-hydroxylase in rat liver. Biochemical Pharmacology. 50(3). 311–316. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathan A. Lack Breakdown of academic impact, for papers by Natale D’Alessandro Breakdown of academic impact, for papers by Huameng Li Breakdown of academic impact, for papers by P. Benedetti Panici Breakdown of academic impact, for papers by T. E. Witzig Breakdown of academic impact, for papers by N. Hirayama Breakdown of academic impact, for papers by Helena Almqvist Breakdown of academic impact, for papers by Aijun Shen Breakdown of academic impact, for papers by Valentina Zuco Breakdown of academic impact, for papers by Helen Boyd
Rankless by CCL
2026